Target Name: CCDC82
NCBI ID: G79780
Review Report on CCDC82 Target / Biomarker Content of Review Report on CCDC82 Target / Biomarker
CCDC82
Other Name(s): CCD82_HUMAN | Coiled-coil domain-containing protein 82 | CCDC82 variant 2 | coiled-coil domain containing 82 | HSPC048 | Coiled-coil domain containing 82, transcript variant 2 | Coiled-coil domain-containing protein 82 (isoform a)

CD82: A Protein Involved in The Immune Response and Cell Signaling

CCDC82 (CCD82_HUMAN), also known as CD82, is a protein that is expressed in various tissues of the human body. It is a member of the CD82 family, which is known for its role in the immune response. CCDC82 is expressed in a variety of tissues, including the skin, lung, heart, and brain.

One of the key functions of CCDC82 is its role in the immune response. CD82 is a member of the CD82 subfamily, which is involved in the regulation of T cell responses. T cells are a type of immune cell that play a critical role in protecting the body against infection and disease. CD82 helps to regulate the activity of T cells by controlling the movement of these cells into the body's tissues.

In addition to its role in the immune response, CCDC82 is also involved in the regulation of cell signaling processes. For example, studies have shown that CCDC82 can interact with the protein PDGF-BB, which is involved in cell signaling. This interaction between CCDC82 and PDGF-BB may have implications for the regulation of cell behavior and the development of certain diseases.

CCDC82 has also been shown to be involved in the regulation of cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. CCDC82 is involved in the regulation of cell adhesion between different tissues, which is important for the development and maintenance of tissues and organs.

In addition to its role in the immune response and cell signaling, CCDC82 is also involved in the regulation of cell death. Studies have shown that CCDC82 can interact with the protein p53, which is involved in the regulation of cell death. This interaction between CCDC82 and p53 may have implications for the regulation of cell death and the risk of certain diseases.

CCDC82 is also of interest as a potential drug target. The immune system is a key target for many diseases, including cancer. CCDC82 is involved in the regulation of T cell responses, which are a critical part of the immune system. By targeting CCDC82, Researchers may be able to develop new treatments for diseases that are caused by imbalances in the immune system.

In addition to its potential as a drug target, CCDC82 is also of interest as a biomarker. The immune system is a critical part of the body's defense against infection and disease. By measuring the levels of CCDC82 in different tissues, researchers may be able to gain insights into the health of the immune system and the risk of certain diseases.

Overall, CCDC82 is a protein that is involved in a variety of important functions in the immune system. Its role in the regulation of T cell responses, cell signaling, cell adhesion, and cell death makes it an attractive target for researchers who are seeking new treatments for diseases. Furthermore, its potential as a biomarker for immune system function makes it an important tool for understanding the health of the immune system and the risk of disease.

Protein Name: Coiled-coil Domain Containing 82

The "CCDC82 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC82 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCDC83 | CCDC85A | CCDC85B | CCDC85C | CCDC86 | CCDC87 | CCDC88A | CCDC88B | CCDC88C | CCDC89 | CCDC9 | CCDC90B | CCDC91 | CCDC92 | CCDC92B | CCDC93 | CCDC96 | CCDC97 | CCDC9B | CCDST | CCEPR | CCER1 | CCER2 | CCHCR1 | CCIN | CCK | CCK receptor | CCKAR | CCKBR | CCL1 | CCL11 | CCL13 | CCL14 | CCL15 | CCL15-CCL14 | CCL16 | CCL17 | CCL18 | CCL19 | CCL2 | CCL20 | CCL21 | CCL22 | CCL23 | CCL24 | CCL25 | CCL26 | CCL27 | CCL28 | CCL3 | CCL3-AS1 | CCL3L1 | CCL3L3 | CCL3P1 | CCL4 | CCL4L1 | CCL4L2 | CCL5 | CCL7 | CCL8 | CCM2 | CCM2L | CCN1 | CCN2 | CCN3 | CCN4 | CCN5 | CCN6 | CCNA1 | CCNA2 | CCNB1 | CCNB1IP1 | CCNB2 | CCNB2P1 | CCNB3 | CCNC | CCND1 | CCND2 | CCND2-AS1 | CCND3 | CCNDBP1 | CCNE1 | CCNE2 | CCNF | CCNG1 | CCNG2 | CCNH | CCNI | CCNI2 | CCNJ | CCNJL | CCNK | CCNL1 | CCNL2 | CCNO | CCNP | CCNQ | CCNQP1 | CCNT1 | CCNT2